5.50
5.50 (0%)
As of Mar 20, 2023
Graybug Vision, Inc. [GRAY]
Source:
Company Overview
Calcimedica, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage.
| Country | United States |
| Headquarters | la jolla, california |
| Phone Number | (858) 952-5500 |
| Industry | manufacturing |
| CEO | A. Rachel Leheny, Ph.D. |
| Website | calcimedica.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | |
| Net Income | $-13.7 |
| Net Cash | $2.4 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -85.7% |
| Profit as % of Stockholder Equity | -95.1% |
Management Effectiveness
| Return on Equity | -95.1% |
| Return on Assets | -69.2% |
| Turnover Ratio | |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $19.8 |
| Total Liabilities | $5.4 |
| Operating Cash Flow | $-21.1 |
| Investing Cash Flow | $-4.4 |
| Financing Cash Flow | $28 |
